home All News open_in_new Full Article

Purdue Pharma hearings begin on $7.4 billion opioid settlement plan

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners.


today 3 d. ago attach_file Economics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Sport
attach_file Politics
attach_file Sport
attach_file Politics
attach_file Sport
attach_file Events
attach_file Sport
attach_file Events
attach_file Events
attach_file Politics
attach_file Sport
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Sport


ID: 547683036
Add Watch Country

arrow_drop_down